Gv 2019 Gp, L.l.c. - Net Worth and Insider Trading

Gv 2019 Gp, L.l.c. Net Worth

The estimated net worth of Gv 2019 Gp, L.l.c. is at least $47 Million dollars as of 2024-11-05. Gv 2019 Gp, L.l.c. is the 10% Owner of Prime Medicine Inc and owns about 11,862,498 shares of Prime Medicine Inc (PRME) stock worth over $47 Million. Details can be seen in Gv 2019 Gp, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gv 2019 Gp, L.l.c. has not made any transactions after 2023-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gv 2019 Gp, L.l.c.

To

Gv 2019 Gp, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gv 2019 Gp, L.l.c. owns 4 companies in total, including Decibel Therapeutics Inc (DBTX) , IonQ Inc (IONQ) , and Verve Therapeutics Inc (VERV) among others .

Click here to see the complete history of Gv 2019 Gp, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Gv 2019 Gp, L.l.c.

Ticker Comapny Transaction Date Type of Owner
DBTX Decibel Therapeutics Inc 2021-02-11 10 percent owner
IONQ IonQ Inc 2021-09-30 10 percent owner
VERV Verve Therapeutics Inc 2021-06-16 10 percent owner
LIMIT LIMIT 2023-06-21 10 percent owner

Gv 2019 Gp, L.l.c. Latest Holdings Summary

Gv 2019 Gp, L.l.c. currently owns a total of 1 stock. Gv 2019 Gp, L.l.c. owns 11,862,498 shares of Prime Medicine Inc (PRME) as of June 21, 2023, with a value of $47 Million.

Latest Holdings of Gv 2019 Gp, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRME Prime Medicine Inc 2023-06-21 11,862,498 3.96 46,975,492

Holding Weightings of Gv 2019 Gp, L.l.c.


Gv 2019 Gp, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Gv 2019 Gp, L.l.c. has made a total of 16 transactions in Prime Medicine Inc (PRME) over the past 5 years, including 1 buys and 15 sells. The most-recent trade in Prime Medicine Inc is the sale of 56,408 shares on June 21, 2023, which brought Gv 2019 Gp, L.l.c. around $847,812.

Insider Trading History of Gv 2019 Gp, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gv 2019 Gp, L.l.c. Trading Performance

GuruFocus tracks the stock performance after each of Gv 2019 Gp, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gv 2019 Gp, L.l.c. is 10.92%. GuruFocus also compares Gv 2019 Gp, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Gv 2019 Gp, L.l.c. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gv 2019 Gp, L.l.c.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gv 2019 Gp, L.l.c.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.54 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 23.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Gv 2019 Gp, L.l.c. Ownership Network

Ownership Network List of Gv 2019 Gp, L.l.c.

No Data

Ownership Network Relation of Gv 2019 Gp, L.l.c.

Insider Network Chart

Gv 2019 Gp, L.l.c. Owned Company Details

What does Decibel Therapeutics Inc do?

Who are the key executives at Decibel Therapeutics Inc?

Gv 2019 Gp, L.l.c. is the 10 percent owner of Decibel Therapeutics Inc. Other key executives at Decibel Therapeutics Inc include See Remarks James B Murphy , See Remarks Anna Trask , and director & See Remarks Laurence Reid .

Decibel Therapeutics Inc (DBTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Decibel Therapeutics Inc Insider Transactions

No Available Data

Gv 2019 Gp, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Gv 2019 Gp, L.l.c.. You might contact Gv 2019 Gp, L.l.c. via mailing address: 1600 Amphitheatre Pkwy, Mountain View Ca 94043.